-+ 0.00%
-+ 0.00%
-+ 0.00%

Clear Street Maintains Buy on Ocular Therapeutix, Raises Price Target to $28

Benzinga·03/03/2026 10:06:48
Listen to the news
Clear Street analyst Bill Maughan maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $21 to $28.